Investment analysts at StockNews.com started coverage on shares of Veradigm (NASDAQ:MDRX – Get Free Report) in a research note issued to investors on Wednesday. The brokerage set a “hold” rating on the software maker’s stock.
Separately, Stephens upped their price target on shares of Veradigm from $7.00 to $13.00 and gave the stock an “equal weight” rating in a research note on Friday, January 31st.
View Our Latest Research Report on MDRX
Veradigm Stock Down 2.5 %
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
See Also
- Five stocks we like better than Veradigm
- What Do S&P 500 Stocks Tell Investors About the Market?
- D-Wave: Multiple Use Cases Emerge Following Quantum Supremacy
- What Are Some of the Best Large-Cap Stocks to Buy?
- Amazon Falls Back to a Key Support Line: Here’s How to Play It
- Investing in the High PE Growth Stocks
- Buffett Trims Equities, But Still Keeps Buying This Stock
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
